Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta-analysis
The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Background Interleukin-6 (IL-6) is an important mediator of atherosclerotic disease and is also associated with coronary artery disease (CAD). The growing evidences suggest that polymorphisms in the IL-6 promoter region influence the progression of CAD. This study was performed to update the systematic results of association of IL-6 gene polymorphisms with CAD.Methods PubMed, Embase, and China Biology Medicine were searched systematically for English and Chinese articles published up to October 31, 2014. Data were extracted using standardized forms. Odds ratios (ORs) with 95 % confidence intervals (CIs) were used to assess the strength of associations. Subgroup analyses were made on ethnicity.Results A total of 42 studies including 15,145 cases and 21,496 controls were combined in this meta-analysis. IL-6 gene -174G/C polymorphism was associated with an increased risk of CAD (for C allele versus G allele: OR = 1.11, 95 % CI 1.02-1.20; for C/C versus G/G: OR = 1.21, 95 % CI 1.03-1.42; for C/C + C/G versus G/G: OR = 1.14, 95 % CI 1.03-1.27). In the subgroup analyses based on ethnicity, a significant association was found between -174 G/C polymorphism and CAD in Caucasians (for C allele versus G allele: OR = 1.12, 95 % CI 1.03-1.22; for C/C versus G/G: OR = 1.21, 95 % CI 1.02-1.42; for C/C + C/G versus G/G: OR = 1.16, 95 % CI 1.05-1.29). In order to reduce heterogeneity, we removed the outlier studies by a Galbraith plot analysis. As a result, the pooled ORs demonstrated no association of -174G/C polymorphism and CAD (C allele versus G allele: OR = 1.02, 95 % CI 0.97-1.06, p = 0.48; C/C versus G/G: OR = 0.1.03, 95 % CI 0.94-1.13, p = 0.48; C/G + C/C versus G/G: OR = 1.03, 95 % CI 0.96-1.09, p = 0.41; C/C versus C/G + G/G: OR = 1.02, 95 % CI 0.94-1.10, p = 0.70, respectively). The polymorphism of -572 G/C was not associated with CAD significantly (for C allele versus G allele: OR = 0.86, 95 % CI 0.74-1.01; C/C versus G/G: OR = 0.99, 95 % CI 0.43-2.27; C/G + C/C versus G/G: OR = 0.96, 95 % CI 0.80-1.15, respectively). In addition, subgroup analyses showed an association between -572 G/C polymorphism and CAD risk among Chinese (C allele versus G allele: OR = 0.64, 95 % CI 0.48-0.85; C/C versus G/G: OR = 0.38, 95 % CI 0.18-0.81; C/G + C/C versus G/G: OR = 0.47, 95 % CI 0.22-1.00; C/C versus C/G + G/G: OR = 0.58, 95 % CI 0.42-0.81).Conclusion The C allele of -174G/C polymorphism may associate with increased sensibility to CAD among Caucasians in overall analysis. Nevertheless, the effect is interfered by heterogeneity across the included studies. The C allele of -572G/C polymorphism may decrease the risk of CAD in Chinese.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genome-wide association studies (GWAS), meta-analysis, exome analysis and single nucleotide polymorphism (SNP) mapping have associated IL-6, IL-6R and gp130 with inflammatory diseases such as RA and coronary artery disease (263–269).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [264]
In the citing paper
“Carriers of the−174G > C mutation have an increased risk of developing various major diseases, including Alzheimer disease30, CVD31, non-insulin-dependent diabetes mellitus32, bone fragility33, and systemic-onset juvenile chronic arthritis34.”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [31]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · cited 2×
“Begg’s funnel plots were performed to estimate the publication bias in this study [46].”
MethodPreferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955 · cited 1×
“The possibility of publication bias was evaluated by funnel plots [45, 46].”
MethodPreferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation
Terry, C. F., Loukaci, V., & Green, F. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000379200 · Cited by 800 · cited 1×
“The human IL-6 gene is situated in chromosome 7p21 and there are three single nucleotide polymorphisms (SNPs) at the 50 flanking region of the IL-6 gene promoter [6].”
BackgroundBrull, D. J., Montgomery, H. E., Sanders, J., Dhamrait, S., Luong, L., Rumley, A., Lowe, G. D. O., & Humphries, S. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.094280 · Cited by 408
Humphries, S. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2678 · Cited by 388
Thakkinstian, A., McEvoy, M., Minelli, C., Gibson, P., Hancox, B., Duffy, D., Thompson, J., Hall, I., Kaufman, J., Leung, T.-F., et al. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi184 · Cited by 356
Jenny, N. S., Tracy, R. P., Ogg, M. S., Luong, L. A., Kuller, L. H., Arnold, A. M., Sharrett, A. R., & Humphries, S. E. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000040224.49362.60 · Cited by 243
Basso, F., Lowe, G. D. O., Rumley, A., McMahon, A. D., & Humphries, S. E. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000013283.84306.1a · Cited by 172
Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study
Georges, J.-L., Loukaci, V., Poirier, O., Evans, A., Luc, G., Arveiler, D., Ruidavets, J.-B., Cambien, F., & Tiret, L. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100209 · Cited by 170 · cited 1×
“[17], no significant heterogeneity was found in the additive model (for C/C versus G/G: p = 0.”
BackgroundNauck, M., Winkelmann, B. R., Hoffmann, M. M., Böhm, B. O., Wieland, H., & März, W. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0354-2 · Cited by 128
Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction
Bennet, A. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.029 · Cited by 113
Association of Serum Interleukin-6 Concentration with a Functional IL6 −6331T>C Polymorphism
Smith, A. J. P., D’Aiuto, F., Palmen, J., Cooper, J. A., Samuel, J., Thompson, S., Sanders, J., Donos, N., Nibali, L., Brull, D., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.098608 · Cited by 87 · cited 1×
“It has been reported that the IL-6 gene affects the serum level of IL-6, which is strongly associated with the physiopathologic process of CAD [10, 33, 50].”
BackgroundMeta-analysis for orthodontists: Part I – How to choose effect measure and statistical model
Papageorgiou, S. N. (2014) · Journal of Orthodontics · doi:10.1179/1465313314y.0000000111 · Cited by 82 · cited 1×
“A fixed effect model was used to calculate pooled OR when I(2)\ 50 %; otherwise, a random effect model was adopted to combine the data [44].”
MethodBanerjee, I., Gupta, V., Ahmed, T., Faizaan, M., Agarwal, P., & Ganesh, S. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.08.007 · Cited by 82
Lieb, W., Pavlik, R., Erdmann, J., Mayer, B., Holmer, S. R., Fischer, M., Baessler, A., Hengstenberg, C., Loewel, H., Doering, A., et al. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.07.038 · Cited by 76
TLR4 signaling: A potential therapeutic target in ischemic coronary artery disease
Jia, S., Niu, P.-P., Cong, J.-Z., Zhang, B., & Zhao, M. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.08.011 · Cited by 73 · cited 1×
“Previous researchers have reported that CAD is a chronic inflammatory process, suggesting that inflammatory cytokines play a major role in the progression of CAD [2, 3].”
BackgroundZintzaras, E., Rodopoulou, P., & Sakellaridis, N. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwn368 · Cited by 73 · cited 1×
“HWEof genotype in controlwas tested with an online HWE calculator [43], and the significant cutoff was set at p value\0.”
MethodInterleukin‐6 gene polymorphism is an age‐dependent risk factor for myocardial infarction in men
Chiappelli, M., Tampieri, C., Tumini, E., Porcellini, E., Caldarera, C. M., Nanni, S., Branzi, A., Lio, D., Caruso, M., Hoffmann, E., et al. (2005) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2005.00537.x · Cited by 67
Shanker, J., Dash, D., John, S., Sannappa, P. R., Rao, V. S., Ramanna, J. K., Kakkar, V. V., & Maitra, A. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-11-0686 · Cited by 63
Licastro, F., Chiappelli, M., Caldarera, C. M., Tampieri, C., Nanni, S., Gallina, M., & Branzi, A. (2004) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(04)00133-2 · Cited by 59
Banerjee, I., Pandey, U., Hasan, O. M., Parihar, R., Tripathi, V., & Ganesh, S. (2007) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-007-0184-8 · Cited by 51
Satti, H. S., Hussain, S., & Javed, Q. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/538365 · Cited by 49
Kelberman, D., Hawe, E., Luong, L. A., Mohamed‐Ali, V., Lundman, P., Tornvall, P., Aillaud, M. F., Juhan-Vague, I., Yudkin, J. S., Margaglione, M., et al. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-04-0202 · Cited by 47
Fan, W., Liu, D., Xiao, L., Xie, C., Sun, S., & Zhang, J. (2010) · Oral Diseases · doi:10.1111/j.1601-0825.2010.01736.x · Cited by 45
Figura, N., Palazzuoli, A., Vaira, D., Campagna, M., Moretti, E., Iacoponi, F., Giordano, N. G., Clemente, S., Nuti, R., & Ponzetto, A. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201743 · Cited by 43
Elsaid, A. M. M., Abdel‐Aziz, A., Elmougy, R., & El-Waseef, A. (2014) · PubMed · Cited by 41
Rios, D. L. S., de Cerqueira, C. C. S., Bonfim-Silva, R., Araújo, L. J., PEREIRA, J. F., Gadelha, S. R., & Barbosa, A. A. L. (2010) · Cytokine · doi:10.1016/j.cyto.2010.02.012 · Cited by 40
Phulukdaree, A., Khan, S., Ramkaran, P., Govender, R., Moodley, D., & Chuturgoon, A. A. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0130 · Cited by 40
Preis, S. R., Ridker, P. M., Zee, R. Y. L., & Cook, N. R. (2005) · Human Genetics · doi:10.1007/s00439-005-0052-6 · Cited by 39
Gürkan, A. Ç., Arman, A., Soylu, O., Tezel, T., & Yildirim, A. (2011) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2010.00988.x · Cited by 38
Sun, K., Li, Y., Wei, C., Tong, Y., Zheng, H., & Guo, Y. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.001 · Cited by 38 · cited 1×
“The quality of each individual study was assessed by two reviewers according to predefined scale for quality standard (Sun [40] and Thakkinstian [41] ).”
MethodBennermo, M. B., Nordin, M., Lundman, P., Boqvist, S., Held, C., Samnegård, A., Ericsson, C.-G., Silveira, A. M. V., Hamsten, A., Nastase, M. M., et al. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0036 · Cited by 38 · cited 1×
“It has been reported that the IL-6 gene affects the serum level of IL-6, which is strongly associated with the physiopathologic process of CAD [10, 33, 50].”
BackgroundMayyas, F., AL-JARRAH, M. I., Ibrahim, K. S., & Alzoubi, K. H. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2034 · Cited by 37
Park, S., Youn, J., Shin, D.-J., Park, C. M., Kim, J., Ko, Y., Choi, D., Ha, J., Jang, Y., & Chung, N. (2007) · Coronary Artery Disease · doi:10.1097/mca.0b013e328241d967 · Cited by 35
Şekuri, C., Çam, F. S., Sağcan, A., Ercan, E., Tengiz, İ., Alioğlu, E., & Berdelı, A. (2007) · Coronary Artery Disease · doi:10.1097/mca.0b013e32820588ae · Cited by 34
Yin, Y.-W., Li, J.-C., Zhang, M., Wang, J., Li, B., Liu, Y., Liao, S.-Q., Zhang, M.-J., Gao, C., & Zhang, L. (2013) · Gene · doi:10.1016/j.gene.2013.07.074 · Cited by 33
Zhou, Q., Wang, C., Wang, X., Wu, X., Zhu, Z., Liu, B., & Su, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109605 · Cited by 31 · cited 1×
“The studies selected met the following criteria: (1) the original study was based on case–control study design; (2) the genotype distribution information of subjects and the sample size were offered, and sources of subjects were clear; (3) for the same or reduplicative data in different papers, the most latest or larg…”
MethodSelf-citationSarecka, B., Żak, I., & Krauze, J. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.01.028 · Cited by 30
-174G>C Interleukin-6 Gene Polymorphism in Tunisian Patients with Coronary Artery Disease
Ghazouani, L., Abboud, N., Khalifa, S. B. H., Added, F., Khalfallah, A., Nsiri, B., Mediouni, M., & Mahjoub, T. (2011) · Annals of Saudi Medicine · doi:10.4103/0256-4947.75777 · Cited by 29 · cited 1×
“7 kDa, is one of the important inflammatory cytokines and regulates the inflammatory response of CAD [4, 5].”
BackgroundGalimudi, R. K., Spurthi, K. M., Padala, C., Kumar, K., Mudigonda, S., Reddy, S. G., Tupurani, M. A., Sahu, S. K., & Hanumanth, S. R. (2013) · Inflammation · doi:10.1007/s10753-013-9742-8 · Cited by 28
TNF-α −308G > A and IL-6 −174G > C polymorphisms in Tunisian patients with coronary artery disease
Ghazouani, L., Khalifa, S. B. H., Abboud, N., Hamda, K. B., Khalfallah, A., Brahim, N., Almawi, W. Y., & Mahjoub, T. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.05.005 · Cited by 27
George, S. K., Ruan, X. Z., Navarrete, C., Turner, D. M., Reynard, M., Sweny, P., Hamilton, G., Wheeler, D. C., Powis, S. H., Moorhead, J. F., et al. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00183.x · Cited by 25
Piira, O.-P., Miettinen, J. A., Hautala, A. J., Huikuri, H. V., & Tulppo, M. P. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.06.001 · Cited by 23
Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries.
Myśliwska, J. M., Więckiewicz, J., Hak, Ł., Siebert, J., Rogowski, J. A., Szyndler, K., & Myśliwski, A. (2006) · PubMed · Cited by 23
Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction
Vakili, H., Ghaderian, S. M. H., Akbarzadeh, R., Panah, A. S. T., & Azargashb, E. (2011) · Coronary Artery Disease · doi:10.1097/mca.0b013e328346b848 · Cited by 23
Jia, X., Tian, Y., Wang, Y., Deng, X., Dong, Z., Scafa, N., & Zhang, X. (2010) · PubMed · Cited by 21
Mahalle, N. P., Garg, M., Kulkarni, M. R., & Naik, S. (2014) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.141525 · Cited by 20 · cited 1×
“7 kDa, is one of the important inflammatory cytokines and regulates the inflammatory response of CAD [4, 5].”
Background6. Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction
Ghaderian, S. M. H., Najar, R. A., Panah, A. S. T., Vakili, H., & Azargashb, E. (2011) · Heart & Lung · doi:10.1016/j.hrtlng.2011.04.008 · Cited by 17
Wei, Y., Lan, Y., Liu, Y., Tang, R.-G., & Lan, J.-S. (2006) · PubMed · Cited by 17
Gene polymorphisms in patients below 35 years of age who underwent coronary artery bypass surgery
n, U. T. T., Aks??yek, A., Ulus, A. T., lu, M. G. M., lu, F. I. E. I., k, K. Z., Parlar, A. İ., Budak, A. B., Gedik, S., & lu, S. F. K. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200602000-00006 · Cited by 15
[Interleukin-6-597G/A and -572C/G polymorphisms and risk of coronary heart disease].
Fu, H., Li, G.-S., Li, Y., Xu, J., & Zhang, J. (2006) · PubMed · Cited by 12
Relationship between coronary heart disease and polymorphisms of interleukin-6 gene
Li, Y. (2005) · Zhonghua jianyan yixue zazhi · Cited by 8
Relationship between coronary heart disease and polymorphisms of interleukin-6 gene
李艳, Yang, C. Q., 张平安, 蒋学俊, & 黄从新 (2005) · Zhonghua jianyan yixue zazhi · doi:10.3760/j:issn:1009-9158.2005.04.010 · Cited by 8
Rostoff, P., Szczeklik, W., Piwowarska, W., Konduracka, E., Sanak, M., & Nessler, J. (2014) · PubMed · Cited by 4
Cited by
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453
Pleiotropy and specificity: insights from the interleukin 6 family of cytokines
Murakami, M., Kamimura, D., & Hirano, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.027 · Cited by 533
Aliyu, M., Zohora, F. T., Anka, A. U., Ali, K., Maleknia, S., Saffarioun, M., & Azizi, G. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109130 · Cited by 401
Regulation of IL-6 in Immunity and Diseases
Tanaka, T., Narazaki, M., Masuda, K., & Kishimoto, T. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-024-0921-5_4 · Cited by 235
Metadata
- Authors
- Hou, H., Wang, C., Sun, F., Zhao, L., Dun, A., & Sun, Z.
- Affiliations
- Taishan Medical University (CN)
- Corresponding author
- Hou, Haifeng
- Sun, Zheng
- Venue
- Inflammation Research
- Published
- 2015-07-15
- Volume
- 64
- Issue
- 9
- Pages
- 707-720
- ISSN
- 1023-3830 (ISSN-L)
- 1420-908X
- OpenAlex
- W1462845024
- Cited by
- 55
- References
- 58
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2022: 10 · 2021: 3 · 2020: 11 · 2019: 7 · 2018: 10 · 2017: 6 · 2016: 4
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Inflammation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81202170)
- Taian Science and Technology Foundation (20103012)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- interleukin-6, IL-6 gene polymorphism, coronary artery disease, IL-6 promoter, genetic susceptibility, atherosclerosis, ethnic differences, genetic association studies, cardiovascular risk factors, lipid metabolism, smoking, alcohol consumption, physical activity, body mass index, hypertension, dyslipidemia
- MeSH terms
- Coronary Artery Disease, Humans, Interleukin-6, Odds Ratio, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.